Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRR | Q9GZT4 | 3/20 | 0.70 |
| ▸ | PPARG | P37231 | 17/20 | 0.65 |
| ▸ | PPARA | Q07869 | 15/20 | 0.65 |
| ▸ | PPARD | Q03181 | 3/20 | 0.63 |
| ▸ | PSAT1 | Q9Y617 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16877217 | 1.00 | SRR (0.70) | SRRPPARGPPARAPPARDPSAT1 | |
| SCHEMBL2517934 | 1.00 | SRR (0.70) | SRRPPARGPPARAPPARDPSAT1 | |
| SCHEMBL8091095 | 0.86 | SRR (0.58) | SRRPPARGPPARAPPARD | |
| SCHEMBL12141661 | 0.86 | SRR (0.58) | SRRPPARGPPARAPPARD | |
| SCHEMBL5606931 | 0.86 | PPARA (0.74) | PPARGPPARAPPARD | |
| SCHEMBL4780746 | 0.85 | SRR (0.61) | SRRPPARGPPARAPPARDPSAT1 | |
| SCHEMBL7150900 | 0.85 | SRR (0.56) | SRRPPARGPPARAPPARD | |
| Hydrochloric Acid SCHEMBL5754335 | 0.85 | SRR (0.61) | SRRPPARGPPARAPPARDPSAT1 | |
| SCHEMBL4451311 | 0.85 | PPARA (0.56) | SRRPPARGPPARAPPARDPSAT1 | |
| SCHEMBL3466702 | 0.85 | PPARA (0.56) | SRRPPARGPPARAPPARDPSAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12415835-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-16 | — | — | US | disclosed |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-05-23 | — | — | US | disclosed |
| US-11891457-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-02-06 | — | — | US | disclosed |
| US-20230399297-A1 | Novel Glutamine Analogs | JACOBIO PHARMACEUTICALS CO., LTD (CN) | 2023-12-14 | — | — | US | disclosed |
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | RAYZEBIO, INC. | 2023-05-25 | — | — | US | disclosed |
| WO-2022078416-A1 | NOVEL GLUTAMINE ANALOGS | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2022-04-21 | — | — | WO | disclosed |
| EP-3974563-A1 | CYCLIC PEPTIDES | Chugai Seiyaku Kabushiki Kaisha (JP) | 2022-03-30 | — | — | EP | disclosed |
| EP-2813512-B1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2021-03-31 | — | — | EP | disclosed |
| US-20210061860-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2021-03-04 | — | — | US | disclosed |
| US-20210061860-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2021-03-04 | — | — | US | disclosed |
| US-20150080549-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2015-03-19 | — | — | US | disclosed |
| US-20150080549-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2015-03-19 | — | — | US | disclosed |
| EP-2813512-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | Chugai Seiyaku Kabushiki Kaisha (JP) | 2014-12-17 | — | — | EP | disclosed |
| EP-2813512-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | Chugai Seiyaku Kabushiki Kaisha (JP) | 2014-12-17 | — | — | EP | disclosed |
| WO-2013100132-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | 中外製薬株式会社 (JP) | 2013-07-04 | — | — | WO | disclosed |
| US-20090175792-A1 | GLYCOMIMETIC INHIBITORS OF SIGLEC-8 | GLYCOMIMETICS, INC. (US) | 2009-07-09 | — | — | US | disclosed |
| US-20090175792-A1 | GLYCOMIMETIC INHIBITORS OF SIGLEC-8 | GLYCOMIMETICS, INC. (US) | 2009-07-09 | — | — | US | disclosed |
| EP-0334845-B1 | LIQUID CRYSTAL COMPOUNDS, MIXTURES AND DEVICES | The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and (GB) | 1992-05-06 | — | — | EP | disclosed |
| US-5037576-A | Ferroelectric; increased polarization | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1991-08-06 | — | — | US | disclosed |
| WO-1988002390-A2 | LIQUID CRYSTAL COMPOUNDS, MIXTURES AND DEVICES | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNI (GB) | 1988-04-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11891457-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | SRR 3833/4885PPARG 3973/4885PPARA 3215/4885 |
| US-20210061860-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | VIP, NGLY1, GLP1R | SRR 3833/4885PPARG 3973/4885PPARA 3215/4885 |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | VIP, NGLY1, GLP1R | SRR 3833/4885PPARG 3973/4885PPARA 3215/4885 |
| US-20230399297-A1 | Novel Glutamine Analogs | GLUL, GATD3, GLS | SRR 3147/4885PPARG 1211/4885PPARA 1857/4885 |
| US-20090175792-A1 | GLYCOMIMETIC INHIBITORS OF SIGLEC-8 | SIGLEC7, SIGLEC9, FUT8 | SRR 3387/4885PPARG 4434/4885PPARA 4689/4885 |
| US-20150080549-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | VIP, NGLY1, GLP1R | SRR 3833/4885PPARG 3973/4885PPARA 3215/4885 |
| US-20230158179-A1 | RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF | PAICS, LNPEP, DNPEP | SRR 2304/4885PPARG 2794/4885PPARA 2801/4885 |
| US-12415835-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | SRR 3833/4885PPARG 3973/4885PPARA 3215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.